Clinical trials recruiting for Lung Carcinoma

Phase breakdown

Drugs and treatments being studied

Where trials are recruiting (top US states)

Top cities

Self-screener

Recruiting trials

• 68Ga-grazytracer PET Assists in Diagnosing Pseudoprogression Following Immunotherapy in Lung Cancer.
  NCT06608160 · Phase: Not specified · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location
• A Restorative Justice-Based Lung Cancer Screening Decision-Making Support Intervention Tailored for Black Individuals to Increase Lung Cancer Screening Among Black Community Members, RESTORE Trial
  NCT07490860 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 77 Years · Sex: All (male and female) · 1 location
• A Self-Monitoring Platform for Tracking Medication Safety and Concerns in Cancer Patients
  NCT07291414 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• A Study of SKB518 in Patients With Lung Cancer
  NCT07019675 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 17 locations
• CONNECTing to LungCare
  NCT06213532 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Canakinumab for the Prevention of Lung Cancer, the Can-Prevent-Lung Trial
  NCT04789681 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Continuous Positive Airway Pressure Device or Deep Inspiration Breath Hold in Reducing Tumor Motion in Patients Undergoing Stereotactic Body Radiation Therapy for Lung Cancer
  NCT03422302 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Data Collection for the Assessment of Acute and Late Normal Tissue in Patients Treated With Proton Therapy
  NCT00991094 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Educating Smokers About Lung Cancer Screening Using Tobacco Quitlines
  NCT04595422 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Engagement of Veterans With Lung Cancer
  NCT07219251 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Enhanced COPD Management in Suspected Lung Cancer Patients
  NCT07543601 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Feasibility of Cell-Free DNA Liquid Biopsy in Screening High-Risk Patients for Lung Cancer
  NCT05384769 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 1 location
• Improving Decision-Making Encounters in Lung Cancer Using a Low-Literacy Conversation Tool
  NCT05407168 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years to 99 Years · Sex: All (male and female) · 4 locations
• Investigating the Feasibility and Acceptability of an Innovative Interdisciplinary Supportive Care Program: Couples Coping Together Against Cancer
  NCT07664579 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Lung Cancer Screening in High-risk Black Individuals
  NCT05898594 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 80 Years · Sex: All (male and female) · 2 locations
• Molecular Analysis of Suspected or High-Risk Lung Cancer to Drive Individualized Care (Interception for Suspected Lung Cancer)
  NCT06482073 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Novel INPUT Screening Tool to Improve Illness Understanding in Patients With Metastatic or Incurable Lung Cancer
  NCT06743308 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PET-imaging of Two Vartumabs in Patients With Solid Tumors
  NCT06645808 · Phase: Early Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• PET/CT Imaging to Evaluate Cardiac Radiation Damage in Patients With Lung or Esophageal Cancer, EUCLID Trial
  NCT05775939 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
  NCT03582124 · Phase: Phase 1, Phase 2 · Ages: 19 Years and older · Sex: All (male and female) · 1 location
• Patient-Derived Xenografts to Reduce Cancer Health Disparities
  NCT04410302 · Phase: Not specified · Ages: 21 Years to 100 Years · Sex: All (male and female) · 2 locations
• Stereotactic Body Radiation Therapy Planning With Artificial Intelligence-Directed Dose Recommendation for Treatment of Primary or Metastatic Lung Tumors, RAD-AI Study
  NCT05802186 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Support and Outreach to Increase Screening for Lung Cancer in Patients With a History of Smoking
  NCT05679349 · Phase: Not applicable (e.g. observational or device study) · Ages: 50 Years to 77 Years · Sex: All (male and female) · 1 location
• Tailored Patient Navigation to Improve the Uptake of Lung Cancer Screening in Tribal Communities in Western Washington State, SACRED LUNGS Trial
  NCT07176000 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• Telephone-based Physical Activity Coaching or Self Monitored Physical Activity to Improve Physical Function in Older Adults Who Are Undergoing Surgery for Lung Cancer and Their Caregivers
  NCT06196008 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 16 locations
• The Cancer Connected Access and Remote Expertise Beyond Walls Program to Provide In-Home Cancer Treatment and Improve Treatment Satisfaction in Cancer Patients Living in the Florida Panhandle and Surrounding Areas
  NCT07285044 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
• The Rise in Robotic Atypical Segmentectomies
  NCT04644952 · Phase: Not specified · Ages: No age limits stated · Sex: All (male and female) · 1 location
• The Vanguard Study: Testing a New Way to Screen for Cancer
  NCT06995898 · Phase: Not applicable (e.g. observational or device study) · Ages: 45 Years to 75 Years · Sex: All (male and female) · 132 locations
• Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
  NCT05978128 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Walking After Surgery to Improve Recovery and Outcomes After Surgery, AIRTECH Study
  NCT04783168 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: All (male and female) · 1 location

Related conditions

Trials recruiting for Lung Carcinoma often also study these conditions. Each links to its own recruiting-trial list.

Common questions

Are these trials free to join?

Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.

How do I know if I am eligible for Lung Carcinoma trials?

Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.

Is this list complete?

No. For the full list, search ClinicalTrials.gov.